These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16391804)

  • 1. in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.
    Inoue Y; Tanaka K; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
    Int J Oncol; 2006 Feb; 28(2):479-86. PubMed ID: 16391804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in p53 mutant human colon cancer.
    Tanaka K; Inoue Y; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
    J Exp Clin Cancer Res; 2007 Jun; 26(2):241-51. PubMed ID: 17725105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.
    Inoue Y; Miki C; Watanabe H; Hiro J; Toiyama Y; Ojima E; Yanagi H; Kusunoki M
    J Gastroenterol; 2006 Dec; 41(12):1149-57. PubMed ID: 17287894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.
    Nakajima TE; Yasunaga M; Kano Y; Koizumi F; Kato K; Hamaguchi T; Yamada Y; Shirao K; Shimada Y; Matsumura Y
    Int J Cancer; 2008 May; 122(9):2148-53. PubMed ID: 18196580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines.
    Grivicich I; Regner A; da Rocha AB; Grass LB; Alves PA; Kayser GB; Schwartsmann G; Henriques JA
    Oncol Res; 2005; 15(7-8):385-92. PubMed ID: 16491956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45.
    Toiyama Y; Tanaka K; Konishi N; Mohri Y; Tonouchi H; Miki C; Kusunoki M
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):368-75. PubMed ID: 16075279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevance.
    Xu JM; Azzariti A; Tommasi S; Lacalamita R; Colucci G; Johnston PG; Church SW; Paradiso A
    Clin Colorectal Cancer; 2002 Nov; 2(3):182-8. PubMed ID: 12482336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
    Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
    Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose.
    Cao S; Rustum YM
    Cancer Res; 2000 Jul; 60(14):3717-21. PubMed ID: 10919639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
    Chen TC; Su S; Fry D; Liebes L
    Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.
    Li XL; Wang CZ; Mehendale SR; Sun S; Wang Q; Yuan CS
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1097-104. PubMed ID: 19277659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
    Kim SL; Kim SH; Trang KT; Kim IH; Lee SO; Lee ST; Kim DG; Kang SB; Kim SW
    Cancer Lett; 2013 Jul; 335(2):479-86. PubMed ID: 23507557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line.
    Guichard S; Hennebelle I; Bugat R; Canal P
    Biochem Pharmacol; 1998 Mar; 55(5):667-76. PubMed ID: 9515577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
    Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
    Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
    González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
    Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
    Yun S; Han YS; Lee JH; Kim S; Lee SH
    Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 20. The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells.
    Grivicich I; Regner A; da Rocha AB; Kayser GB; Schunemann DP; Grass LB; Alves PA; Henriques JA; Schwartsmann G
    Chemotherapy; 2005 May; 51(2-3):93-102. PubMed ID: 15886469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.